Benefit of Continuous Treatment for Responders With Newly Diagnosed Multiple Myeloma in the Randomized FIRST Trial
Leukemia - United Kingdom
doi 10.1038/leu.2017.111
Full Text
Open PDFAbstract
Available in full text
Date
April 4, 2017
Authors
Publisher
Springer Science and Business Media LLC